June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Assessment of Metamorphopsia in Patients with Central Serous Chorioretinopathy
Author Affiliations & Notes
  • Ju Byung Chae
    Ophthalmology-Coll of Med, Chungbuk National University Hospital, Cheong-ju, Chung-buk, Republic of Korea
  • Moses Kim
    Ophthalmology-Coll of Med, Chungbuk National University Hospital, Cheong-ju, Chung-buk, Republic of Korea
  • Sungmin Hyung
    Ophthalmology-Coll of Med, Chungbuk National University Hospital, Cheong-ju, Chung-buk, Republic of Korea
  • Footnotes
    Commercial Relationships Ju Byung Chae, None; Moses Kim, None; Sungmin Hyung, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 257. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ju Byung Chae, Moses Kim, Sungmin Hyung; Assessment of Metamorphopsia in Patients with Central Serous Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):257. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the presence and extent of metamorphopsia using M-CHARTSTM (Inami Co., Tokyo, Japan) in patients with central serous chorioretinopathy (CSC).

Methods: We examined 33 eyes of 33 consecutive CSC patients using M-CHARTS, which yields scores reflecting the severity of metamorphopsia. The condition was considered present when an M-CHARTS score was 0.3 or over. In all patients, optical coherence tomography (OCT) was performed, best-corrected visual acuity (BCVA) was assessed, and M-CHARTS scores were calculated at the first and the 1- and 3-month follow-up visits. The correlation between M-CHARTS scores and BCVA values was determined. We also sought to define relationships between the level of metamorphopsia and specific OCT findings.

Results: Of 33 CSC patients, 15 showed symptoms of metamorphopsia, and all 15 had M-CHARTS scores of over 0.3. However, no correlation was evident between BCVA values and the extent of metamorphopsia as determined using M-CHARTS. In metamorphopsia patients, the incidence of focal retinal pigment epithelial detachment (PED) was notably greater than in the non-metamorphopsia group (p=0.03).

Conclusions: M-CHARTS is valuable for monitoring subjective symptom improvement during the clinical course of CSC. M-CHARTS serves as a useful adjunct to OCT.

Keywords: 452 choroid • 688 retina • 753 vision and action  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×